Loading…
Based on limited metadata, Canadian Chaga received an FDA Warning Letter on August 6, 2020, regarding drug products. Without access to the full letter text or specific subject line, the exact nature of the violations cannot be determined from the available information. The warning was issued under FDA's drug regulatory authority, though the specific issuing office is not identified in the metadata provided. To understand the full scope of compliance concerns, review of the complete Warning Letter would be necessary.